OMSys: Towards a systems model of a bacterial outer membrane

Lead Research Organisation: University of Oxford
Department Name: Biochemistry

Abstract

Many bacteria have an outer membrane which is the interface between the cell and its environment. The components of this membrane are well studied at an individual level, but there is a need to model and understand the outer membrane as a whole. In this project we aim to develop such a model of a bacterial outer membrane, linking computer simulations of the component molecules through to a more 'systems biology' approach to modelling the outer membrane as a whole. Such an approach to modelling an OM must be multi-scale i.e. it must embrace a number of levels ranging from atomistic level modelling of e.g. the component proteins through to higher level 'agent-based' modelling of the interplay of multiple components within the outer membrane as a whole. The different levels of description will be integrated to enable predictive modelling in order to explore the roles of outer membrane changes in e.g. antibiotic resistance.

Technical Summary

In this project we aim to develop a model of a bacterial outer membrane (OM), linking biomolecular simulations through to computational systems biology approaches. Such an approach to modelling an OM must be multi-scale i.e. it must embrace a number of levels: (i) atomistic level modelling of protein/ligand interactions; (ii) coarse-grained modelling of both outer membrane proteins and lipoproteins and of their lipopolysaccharide/phospholipid/peptidoglycan environment; and (iii) higher level e.g. agent-based modelling of the interplay of multiple components within the OM as a whole. The different levels of description will be integrated to enable predictive modelling of bacterial OMs in order to explore the roles of OM changes in e.g. antibiotic resistance and envelope stress responses.

Publications

10 25 50
 
Description We developed methods which allowed us to show massively hindered diffusion of bacterial outer membrane proteins
Exploitation Route collaboration initiated with experimental colleagues
Sectors Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description I have initiated collaborative discussions with a number of pharmaceutical companies (UCB, NovoNordisk, Novartis, Ipsen) interested in large scale membrane simulations using methods which we started to develop during this project.
First Year Of Impact 2015
Sector Pharmaceuticals and Medical Biotechnology
Impact Types Economic